Results 151 to 160 of about 1,662 (181)
Some of the next articles are maybe not open access.
Current Eye Research, 2010
This study sought to evaluate the efficacy of bevacizumab (Avastin), an anti-VEGF agent, in the reduction of corneal neovascularization in a rodent model, and compare between the effect of intraocular and subconjunctival injection.Corneal neovascularization was induced by application of a mixture of 75% silver nitrate and 25% potassium nitrate to the ...
Inbal Avisar +2 more
exaly +3 more sources
This study sought to evaluate the efficacy of bevacizumab (Avastin), an anti-VEGF agent, in the reduction of corneal neovascularization in a rodent model, and compare between the effect of intraocular and subconjunctival injection.Corneal neovascularization was induced by application of a mixture of 75% silver nitrate and 25% potassium nitrate to the ...
Inbal Avisar +2 more
exaly +3 more sources
International Ophthalmology, 2013
The purpose of this study is to determine the effect on endothelial cell density and morphology of combined subconjunctival and intracorneal injection of bevacizumab for the treatment of corneal neovascularization (NV). The charts and specular microscopy images of ten consecutive patients with corneal NV, who received combined subconjunctival ...
Alejandro Lichtinger +2 more
exaly +3 more sources
The purpose of this study is to determine the effect on endothelial cell density and morphology of combined subconjunctival and intracorneal injection of bevacizumab for the treatment of corneal neovascularization (NV). The charts and specular microscopy images of ten consecutive patients with corneal NV, who received combined subconjunctival ...
Alejandro Lichtinger +2 more
exaly +3 more sources
Effect of subconjunctival Bevacizumab injection on the outcome of Ahmed glaucoma valve implantation: a randomized control trial [PDF]
Clinical and Experimental Ophthalmology, 2018 Importance: The effect of subconjunctival Bevacizumab injection on the outcome of Ahmed glaucoma valve (AGV) implantation. Background: Evaluation of efficacy and safety of subconjunctival Bevacizumab injection adjunctive to AGV implantation.
Arezoo Miraftabi +2 more
exaly +1 more source
Human and Experimental Toxicology, 2022 Purpose To investigate the effects of subconjunctival bevacizumab, ranibizumab, and aflibercept in an experimental corneal neovascularization model.
Mehmet Tahir Eski +2 more
exaly +3 more sources
Successful Treatment of Conjunctival Lymphangiectasia With Subconjunctival Injection of Bevacizumab
Cornea, 2016To report a novel intervention for the treatment of conjunctival lymphangiectasia-subconjunctival injection of bevacizumab.A 53-year-old white male presented with a 3-month history of right ocular discomfort and redness unresponsive to conventional topical treatment of lubricants and steroids.
Jeremy C K, Tan +2 more
openaire +2 more sources
Subconjunctival Bevacizumab Injection for Ocular Surface Squamous Neoplasia
Cornea, 2013To determine the efficacy and safety of perilesional/subconjunctival bevacizumab injections in the management of ocular surface squamous neoplasia (OSSN).Ten eyes of 10 patients with an OSSN diagnosis confirmed by impression cytology received 2 perilesional/subconjunctival injections of bevacizumab at a 2-week interval.
Amir, Faramarzi, Sepehr, Feizi
openaire +2 more sources
Cornea, 2011
To report on the safety and clinical use of combined subconjunctival and intracorneal bevacizumab for corneal neovascularization.The charts of 12 consecutive patients with corneal neovascularization who received combined subconjunctival and intracorneal injections of bevacizumab (2.5 mg/0.1 mL) were reviewed.
Sonia N, Yeung +4 more
openaire +2 more sources
To report on the safety and clinical use of combined subconjunctival and intracorneal bevacizumab for corneal neovascularization.The charts of 12 consecutive patients with corneal neovascularization who received combined subconjunctival and intracorneal injections of bevacizumab (2.5 mg/0.1 mL) were reviewed.
Sonia N, Yeung +4 more
openaire +2 more sources
Subconjunctival injection of bevacizumab (Avastin®) for corneal neovascularization
Acta Ophthalmologica, 2009Abstract Purpose to study the effects of subconjunctival injection of Bevacizumab on corneal neovascularization. Methods Prospective interventional case series on 7 eyes of 7 patients who underwent subconjunctival injection with Bevacizumab. The following parameters were studied pre‐op, at 1 week, 30, 60 and 90 days post‐op: UCVA, BCVA, pachymetry with
MF DE LA PAZ +4 more
openaire +1 more source
Cornea, 2008
To report the effect of superficial keratectomy combined with subconjunctival bevacizumab injection in 2 cases of corneal neovascularization (NV).An interventional case series was undertaken on 2 patients with corneal NV: 1 due to sclerokeratitis secondary to rheumatoid arthritis and the other due to Terrien marginal degeneration.
Cynthia Xin-ya, Qian +3 more
openaire +2 more sources
To report the effect of superficial keratectomy combined with subconjunctival bevacizumab injection in 2 cases of corneal neovascularization (NV).An interventional case series was undertaken on 2 patients with corneal NV: 1 due to sclerokeratitis secondary to rheumatoid arthritis and the other due to Terrien marginal degeneration.
Cynthia Xin-ya, Qian +3 more
openaire +2 more sources
Cornea, 2011
To investigate the efficacy of combined photodynamic therapy with verteporfin and subconjunctival injection of bevacizumab for the treatment of patients with corneal neovascularization.Twelve eyes of 12 patients with stable corneal neovascularization who were refractory to conventional treatment were treated with photodynamic therapy with verteporfin ...
In-Cheon, You +3 more
openaire +2 more sources
To investigate the efficacy of combined photodynamic therapy with verteporfin and subconjunctival injection of bevacizumab for the treatment of patients with corneal neovascularization.Twelve eyes of 12 patients with stable corneal neovascularization who were refractory to conventional treatment were treated with photodynamic therapy with verteporfin ...
In-Cheon, You +3 more
openaire +2 more sources